Mechanisms of epithelial cell renewal remain poorly understood in the mammalian kidney, particularly in the glomerulus, a site of cellular damage in chronic kidney disease. Within the glomerulus, podocytes-differentiated epithelial cells crucial for filtration-are thought to lack substantial capacity for regeneration. Here we show that podocytes rapidly lose differentiation markers and enter the cell cycle in adult mice in which the telomerase protein component TERT is conditionally expressed. Transgenic TERT expression in mice induces marked upregulation of Wnt signaling and disrupts glomerular structure, resulting in a collapsing glomerulopathy resembling those in human disease, including HIV-associated nephropathy (HIVAN). Human and mouse HIVAN kidneys show increased expression of TERT and activation of Wnt signaling, indicating that these are general features of collapsing glomerulopathies. Silencing transgenic TERT expression or inhibiting Wnt signaling through systemic expression of the Wnt inhibitor Dkk1 in either TERT transgenic mice or in a mouse model of HIVAN results in marked normalization of podocytes, including rapid cell-cycle exit, re-expression of differentiation markers and improved filtration barrier function. These data reveal an unexpected capacity of podocytes to reversibly enter the cell cycle, suggest that podocyte renewal may contribute to glomerular homeostasis and implicate the telomerase and Wnt-b-catenin pathways in podocyte proliferation and disease. npg a r t i c l e s
Kidney epithelium serves a remarkable array of structural and metabolic functions in mediating the formation and processing of plasma filtrate into urine. Numerous disease processes and drugs target kidney epithelium and impair kidney function, so it is crucial to understand mechanisms of kidney cell renewal in health and in disease. Under steady-state, unstressed conditions, epithelial turnover in the kidney occurs slowly 1 . However, damage to the kidney tubules results in a brisk regenerative response whereby lost cells are replenished from a source intrinsic to the tubular epithelium 2 . In contrast, less is known regarding mechanisms of renewal of epithelial cells within the glomerulus, a complex structure containing capillary loops and multiple cell types that together serve as the kidney filtration unit. Within the glomerulus, podocytes-visceral epithelial cells crucial for effective filtration-are damaged or reduced in number in 90% of chronic kidney diseases in humans 3 .
Depletion of podocytes and the inability to repopulate a damaged glomerulus with functional podocytes ultimately leads to glomerulosclerosis, or scarring of the glomerulus 4, 5 . Diabetes and other systemic disease states can initiate these changes in podocytes, which in turn can result in end-stage renal failure 6, 7 . Podocytes are differentiated cells whose foot processes cover the basement membrane of the glomerulus and form the filtration-slit diaphragms that regulate blood filtration 8 . Mature podocytes do not express proliferation markers, and these observations together with the minimal ability of podocytes to proliferate in response to injury suggest that podocytes have a limited capacity to be replenished during life 9, 10 . However, podocyte proliferation does occur in the rare collapsing variant of focal segmental glomerulosclerosis (FSGS), suggesting that podocytes possess proliferative potential. In two collapsing glomerulopathies, one an idiopathic form of unknown etiology and the other caused by HIV, podocyte dedifferentiation and cell-cycle entry compromise the filtration barrier, leading to severe organ damage 11 . Results from transgenic mouse models of HIVAN implicate the HIV-1 open reading frames nef and vpr as contributors to HIVAN pathogenesis [12] [13] [14] . Cellular pathways involved in the control of the proliferative state of podocytes include vascular endothelial growth factor and the von Hippel-Lindau tumor suppressor 15, 16 . Recent evidence suggests that the parietal cell layer lining Bowman's capsule may provide a niche for cells able to repopulate depleted podocytes in humans and mice 17, 18 . However, little is known about the cellular pathways that govern podocyte renewal in the adult kidney and whether proliferating podocytes can attain a differentiated phenotype.
One pathway important for tissue renewal involves telomerase, an enzyme complex in tissue progenitor cells and cancers that synthesizes telomere repeats, thereby preventing telomere dysfunction, which impairs progenitor cell survival and stem cell self-renewal [19] [20] [21] .
Telomere maintenance by telomerase requires both components of the catalytic core of the enzyme: TERT, the telomerase reverse transcriptase, and TERC, the telomerase RNA component, which is the template for telomere addition. In addition to its role in telomere maintenance, TERT can act as a cofactor to modulate transcriptional responses controlled by the Wnt signaling pathway. Conditional overexpression of TERT in mouse skin activates the bulge stem cells of hair follicles, promoting the active phase of the hair follicle cycle and hair growth. The ability of TERT to activate bulge stem cells is independent of TERC and of catalytic function and therefore operates through a discrete developmental pathway 22, 23 . TERT executes this stem cell activation program by interacting with the chromatinremodeling protein Brg1 at promoter regions of key regulatory genes, including that encoding c-Myc 24 . Here we report that conditional overexpression of TERT in the adult mouse kidney triggers a potent and reversible proliferative response in podocytes by activating the Wnt signaling pathway. Our data show that mature podocytes can reversibly enter the cell cycle and suggest that the telomerase and Wnt pathways are involved in podocyte proliferation and in podocyte disease states.
RESULTS

TERT expression in kidney induces a collapsing glomerulopathy
To determine the effects of TERT on epithelial tissues, we studied mice with doxycycline-inducible TERT (i-TERT), generated by intercrossing tetop-TERT + and β-actin-rtTA + transgenic strains 22 . Mice were weaned at 3 weeks of age and treated with doxycycline-containing drinking water to induce TERT expression. TERT overexpression was induced broadly in adult tissues ( Supplementary Fig. 1a,b) . By age 3 months, many i-TERT mice on doxycycline became moribund and developed abdominal distension caused by ascites, whereas all control mice remained healthy (median survival 115 d, P < 0.001; Fig. 1a ). Liver function tests were normal, and histology of liver and heart was unaffected ( Supplementary Fig. 1c and data not shown). In contrast, kidneys from i-TERT mice on doxycycline showed dilated microcystic tubules ( Fig. 1b) and markedly abnormal glomeruli with wrinkling and retraction of glomerular basement membranes, enlarged, vacuolated podocytes and prominent glomerular epithelial cell hyperplasia ( Fig. 1c,d) . These features are characteristic of the collapsing variant of FSGS in humans 25 and were seen only in i-TERT mice on doxycycline, and never in i-TERT mice off doxycycline or in single-transgenic mice treated with doxycycline, indicating that the phenotype is caused specifically by TERT expression ( Fig. 1c-e and Supplementary Table 1 ).
To understand whether these effects on glomerular histology require the catalytic function of TERT in elongating telomeres, we pursued two complementary strategies. First, we disrupted the telomerase catalytic core by expressing TERT in the absence of Terc. Overexpression of TERT resulted in indistinguishable collapsing glomerulopathies in Terc +/+ , Terc +/− and Terc −/− backgrounds, indicating that TERT can function independently of Terc in this context ( Fig. 1e and Supplementary Table 2 ). Second, we used an allele encoding inducible TERT rendered catalytically inactive through introduction of a point mutation in the active site of the reverse transcriptase domain (i-TERT ci ) 23 . Kidneys from i-TERT ci mice showed a collapsing glomerulopathy similar to that seen in i-TERT mice ( Fig. 1e and Supplementary Table 1 ). Together, these findings indicate that TERT induces a collapsing glomerulopathy through a mechanism that does not require catalytic function.
TERT promotes podocyte proliferation and dedifferentiation
To characterize the glomerular abnormalities caused by TERT expression, we studied TERT expression patterns in wild-type and transgenic kidney. In wild-type mice, telomerase activity measured f P5 S1 P5 S2 P15 S1 P15 S2 P27 S1 P27 S2 NP40 J1 by telomeric repeat amplification protocol (TRAP) and TERT mRNA measured by quantitative RT-PCR (qRT-PCR) were both readily detected in newborn kidney but diminished by age 21 d, paralleling the period of postnatal glomerulogenesis ( Fig. 1f,g) . Whereas telomerase was expressed at very low or undetectable levels in kidneys from adult wild-type mice, transgenic TERT mRNA was specifically upregulated in kidneys from i-TERT mice on doxycycline, as shown by northern blotting (Fig. 1h) .
The β-actin element used to direct expression of rtTA in this model has previously been shown to be preferentially active within the kidney in podocytes 26 , reflecting the key role of the actin cytoskeleton in podocyte function 27 . Consistent with these previous reports, we found by RNA in situ hybridization that transgenic TERT mRNA was enriched in podocytes in i-TERT and i-TERT ci mice on doxycycline ( Fig. 1i and Supplementary Fig. 2a ). To survey podocyte function, we analyzed urine by SDS-PAGE, revealing the presence of abundant albumin in the urine of i-TERT mice on doxycycline ( Fig. 1j) .
These data indicate that TERT is induced in podocytes of i-TERT mice, compromising the ability of these cells to support their normal filtration function.
Podocytes are differentiated and arrested in the G0 phase of the cell cycle 28, 29 . To understand how podocytes are altered by TERT overexpression, we assessed proliferation and differentiation in kidneys from i-TERT mice and controls. Glomeruli from i-TERT and i-TERT ci mice showed a marked increase in the abundance of cells positive for the proliferation marker Ki-67, whereas Ki-67 + cells were rare in controls ( Fig. 2a,b) . These proliferative cells were in positions consistent with both podocytes and parietal epithelial cells lining Bowman's capsule ( Fig. 2a) . Proliferating cells incorporated BrdU, indicating progression through S phase of the cell cycle ( Supplementary Fig. 2b ).
To study cellular differentiation, we analyzed expression of WT1, a transcription factor that marks mature podocytes 30 , and synaptopodin, an actin-associated protein that contributes to foot process formation in differentiated podocytes 31 . Podocytes in i-TERT and i-TERT ci mice on doxycycline showed a profound loss of the podocyte differentiation markers WT1 and synaptopodin ( Fig. 2c-e ). To understand the relationship between the loss of podocyte differentiation markers and the appearance of proliferating cells, we analyzed these markers in a kinetic study in i-TERT ci mice between 7 and 30 d of doxycyline treatment. Loss of synaptopodin expression was evident at the earliest time point (7 d), and WT1 expression was lost more gradually ( Fig. 2f and Supplementary Fig. 2c ). Cell proliferation in glomeruli correlated with WT1 downregulation, reaching a maximum at 12 d with 82% of npg glomeruli harboring Ki-67 + cells in i-TERT ci mice (Fig. 2f) . Apoptotic cells were not identified ( Supplementary Fig. 2d ). Proteinuria was first detected by SDS-PAGE at day 5 and worsened substantially over time ( Fig. 2g) .
To definitively assess whether proliferating cells in the glomerulus included podocytes, we stained cells for both WT1 and Ki-67. WT1 + Ki-67 + double-positive cells were rare, but we detected them in samples from day 12 of the time course, a period in which both WT1 + and Ki-67 + cells coexisted ( Fig. 2h) . Moreover, mitotic figures were evident in podocytes in tissue sections from i-TERT mice (Fig. 2i) . Electron microscopy showed enlargement of podocytes and effacement of foot processes in i-TERT ci mice on doxycycline but preservation of foot processes in control mice on doxycycline ( Fig. 2j ). In addition, podocytes of i-TERT ci mice on doxycycline showed dilated rough endoplasmic reticulum filled with proteinaceous material, consistent with metabolic activation of these cells ( Supplementary  Fig. 2e ). Together, these data indicate that TERT induces proliferation of podocytes and that podocytes enter the cell cycle concomitant with downregulation of WT1.
Activation of the Wnt signaling pathway in podocytes
On the basis of our previous studies linking telomerase to the Wnt program [22] [23] [24] , we hypothesized that activation of Wnt signaling may underlie podocyte activation in i-TERT mice. To investigate the Wnt pathway, we immunostained for β-catenin in kidney sections from i-TERT ci mice. Membranous β-catenin was weakly detected in wildtype podocytes in adherens junctions 32, 33 . In contrast, β-catenin was strongly upregulated in glomeruli of i-TERT ci mice, in a membranous and cytoplasmic pattern, as well as in the nucleus (Fig. 3a) . Cells with increased β-catenin were positive for BrdU, indicating that β-catenin is upregulated in proliferating podocytes (Fig. 3b) . To understand the timing of β-catenin upregulation in this model, we analyzed kidneys from i-TERT ci mice at 12 d after doxycycline treatment, an early time point at which WT1 is still detectable in many glomeruli. At this early time point, cells with high β-catenin expression were also positive for WT1 in i-TERT ci mice on doxycycline ( Fig. 3c) . WT1 signal was reduced in these cells compared to wild-type control, indicating that β-catenin upregulation occurs during dedifferentiation and loss of WT1 and that β-catenin remains elevated once podocytes enter the cell cycle.
To more directly query the Wnt pathway at the transcriptional level, we used a reporter strain in which lacZ was knocked into the endogenous Axin2 gene, a robust target of Wnt signaling 34 . Compound i-TERT ci ;Axin2 LacZ/+ mice were treated with doxycycline for 13 d and kidneys were stained with 5-bromo-4-chloro-3-indolyl-β-dgalactoside (X-gal). In control actin-rtTA + ;Axin2 LacZ/+ mice on doxycycline, β-galactosidase expression was detected in the renal pelvis, with weaker staining in the medulla and cortex. In contrast, β-galactosidase expression was markedly increased in the medulla and cortex but diminished in the renal pelvis in i-TERT ci ;Axin2 LacZ/+ mice on doxycycline ( Fig. 3d) . Analysis of kidney whole mounts showed a pattern consistent with increased β-galactosidase activity within glomeruli in i-TERT ci ;Axin2 LacZ/+ mice on doxycycline (Fig. 3d) . Indeed, immunostaining revealed a specific increase in β-galactosidase protein within glomeruli of i-TERT ci ;Axin2 LacZ/+ mice on doxycycline compared to controls ( Fig. 3e and Supplementary Fig. 3a) . Furthermore, qRT-PCR analysis showed significant upregulation of the Wnt target genes Axin2, cyclin D2 (Ccnd2) and Lef1 in i-TERT ci mice on doxycycline (Fig. 3f) . Together, these results show that the Wnt signaling is activated in proliferating podocytes in i-TERT ci mice.
Increased TERT and Wnt signaling in collapsing glomerulopathies
To determine whether TERT upregulation is a feature of collapsing glomerulopathies, we assessed TERT mRNA levels in kidney samples from humans with HIVAN and in kidneys from a mouse HIVAN model (Tg26 mice) driven by the HIV genome minus the gag and pol open reading frames 14, 35, 36 . In human samples, TERT mRNA was specifically elevated in whole-kidney biopsy specimens from individuals with HIVAN compared to healthy controls (Fig. 4a) . TERT expression and telomerase activity were also upregulated in kidneys from Tg26 mice compared to nontransgenic controls (Fig. 4b,c) . Thus, TERT is commonly upregulated in collapsing glomerulopathies in human and mouse.
To understand whether β-catenin stabilization is a feature of collapsing glomerulopathies, we analyzed β-catenin levels by immunofluorescence in mouse and human samples. In the Tg26 mouse model for HIVAN, we found that β-catenin was strongly upregulated in a membranous and cytoplasmic pattern, as well as within the nucleus, in cells at positions within the glomerulus consistent with podocytes ( Fig. 4d and Supplementary Fig. 3b,c) . Co-staining with Ki-67 revealed that β-catenin was elevated in proliferating podocytes, indicating that, in both i-TERT ci mice and a mouse model of HIVAN podocyte, proliferation is accompanied by marked stabilization of β-catenin ( Fig. 4e) . Increased expression of activated β-catenin in both i-TERT ci and Tg26 mice was further confirmed by western blot analysis for the activated, unphosphorylated form of β-catenin (Fig. 4f) . In healthy human kidneys and in classic FSGS, faint β-catenin staining was detected in glomeruli, consistent with low-level expression in podocyte adherens junctions. In contrast, a marked upregulation of total β-catenin was seen in glomeruli from individuals with HIVAN or ICG ( Fig. 4g-j) . Double immunostaining revealed that many of the cells with stabilized β-catenin were positive for Ki-67 ( Supplementary Fig. 3d ). Quantification of glomeruli carrying stabilized β-catenin showed a similar pattern for either human HIVAN or ICG, with 32% and 28% of glomeruli, respectively, showing a high β-catenin signal ( Fig. 4g  and Supplementary Fig. 3e ). This percentage of glomeruli with high β-catenin was similar to the percentage of glomeruli with Ki-67 + cells in individuals with HIVAN or ICG (Fig. 4g) Wnt signaling (Fig. 4i,j) . Together, these data show that TERT upregulation and β-catenin stabilization are common features of collapsing glomerulopathies and suggest that Wnt activation may be necessary for podocyte proliferation in mouse models and in human disease.
Reversibility of the proliferating podocyte phenotype
Although podocytes proliferate in collapsing glomerulopathies and in i-TERT mice, whether these proliferating cells retain the ability to exit the cell cycle, redifferentiate and resume normal function is unknown. To address this question, we treated six i-TERT ci mice with doxycycline for 13 d, at which point three were killed and the remaining three mice were switched to normal drinking water and aged until at least day 42 (reversed mice ; Fig. 5a ). The severe proteinuria that developed on doxycycline improved in all three reversed mice and was nearly eliminated in two of three i-TERT ci mice within 15 d after doxycycline withdrawal (Fig. 5b) . Whereas all three i-TERT ci mice analyzed after 13 d of doxycycline treatment showed marked podocyte dedifferentiation and abundant proliferating podocytes, reversed i-TERT ci mice analyzed 29 d after withdrawal of doxycycline showed a pronounced normalization of podocytes. Podocytes showed re-expression of WT1 and synaptopodin, and proliferating cells within glomeruli were rare (Fig. 5c,d) . Of glomeruli in reversed i-TERT ci mice, 90% were WT1 + , whereas only 26% of glomeruli expressed WT1 in i-TERT ci mice studied immediately after 13 d of doxycycline (Supplementary Fig. 4a) .
To follow the state of podocytes within a single mouse during doxycycline treatment and after doxycycline withdrawal, we performed survival nephrectomy experiments. After 25 d of doxycycline treatment, two i-TERT ci mice and two actin-rtTA + mice were subjected to unilateral nephrectomy and then switched to normal drinking water and killed after an additional 21 d (Fig. 5a, right) . Whereas 'pre-reversal' kidneys showed podocyte dedifferentiation and cellcycle entry, 'post-reversal' kidneys showed a marked normalization of podocytes, with a prominent reduction in podocyte proliferation and an increase in podocyte differentiation (Fig. 5e,f) .The percentage of WT1-positive glomeruli increased from 27% in the prereversal sample to 64% in the post-reversal kidney (Supplementary Fig. 4b) .
The lower frequency of WT1 + glomeruli (64%) in this doxycyclinewithdrawal experiment compared with the previous reversal experiment that did not incorporate surgery (90%) may reflect the longer duration of doxycycline treatment or the additional hemodynamic and filtration stress on a single kidney in the nephrectomy setting. Histological analysis mirrored the WT1 staining results in reversed i-TERT ci samples, with 61% of glomeruli showing normal morphology and the remaining 39% showing abnormalities more similar to classical FSGS, including discrete segmental or global lesions of sclerosis and hyalinosis (Fig. 5g) . Podocyte density after reversal and recovery in i-TERT ci mice was indistinguishable from controls (Fig. 5h) . Together, these data indicate that the marked dedifferentiation and proliferation of podocytes caused by TERT expression are reversible after TERT is extinguished, enabling a substantial improvement in podocyte function.
Inhibition of Wnt signaling ameliorates disease progression
To assess the requirement for Wnt activation in disease maintenance and progression in our model, we targeted the Wnt-β-catenin pathway by intravenously injecting an adenovirus encoding the Wnt antagonist Figure 5 Proliferating podocytes return to a quiescent, differentiated state after doxycycline withdrawal in i-TERT ci mice. (a) Left, schematic of TERT reversal experiment, using six i-TERT ci mice (see Results). Three mice were killed at day 13 (pre-reversal), and the remaining three were aged until at least 42 d (post-reversal). Data from these mice are shown in b-d. Right, schematic of reversal with nephrectomy, using two actin-rtTA + and two i-TERT ci mice. Each mouse underwent survival nephrectomy at day 25. Data are shown in e-g. 
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Dickkopf-1 (Dkk1), a secreted protein that blocks Wnt signaling at the level of the Wnt co-receptor LRP5/6 (refs. [37] [38] [39] [40] . Injection of adult mice with adenovirus encoding Dkk1 (Ad-Dkk1) results in systemic expression of Dkk1 and has previously been shown to rapidly inhibit canonical Wnt signaling in intestinal epithelial cells 41 . Either Ad-Dkk1 or a control adenovirus expressing an immunoglobulin Fc fragment (Ad-Fc) was injected intravenously into i-TERT ci mice treated with doxycycline for 14 d (Fig. 6a) . The three i-TERT ci mice with the most advanced proteinuria at day 14 were assigned to the Dkk1 treatment group, with the remaining mice treated with Ad-Fc in a control group. Dkk1 effectively inhibited Wnt signaling in the Ad-Dkk1 group, leading to complete effacement of the glandular architecture of the colon, when compared to normal Ad-Fc-injected controls (Supplementary Fig. 4c ). Proteinuria worsened during the time course in mice treated with Ad-Fc ( Supplementary Fig. 4d,e) . In contrast, expression of Ad-Dkk1 in i-TERT ci mice caused a marked reduction in proteinuria within 5-8 d of the injection, indicating a substantial improvement in filtration barrier function ( Fig. 6b and Supplementary Fig. 4e ). The improved podocyte function was specifically due to Dkk1 expression, because proteinuria never diminished in untreated i-TERT mice maintained on doxycycline for up to 56 d (Supplementary Fig. 5a ) and because both podocyte proliferation and dedifferentiation continued to occur in i-TERT and i-TERT ci mice as long as TERT expression was maintained ( Supplementary Fig. 5b−d) . A detailed analysis of the status of podocytes in the Ad-Dkk1 group revealed a notable normalization of podocytes, with a significant increase in podocyte differentiation ( Fig. 6c and Supplementary Fig. 4f , P < 0.0001) and a corresponding reduction in podocyte proliferation ( Fig. 6d and Supplementary Fig. 4g , P < 0.0001).
To evaluate the role of Wnt signaling in the mouse HIVAN model, we intravenously injected either Ad-Dkk1 or Ad-Fc into 5-to 8-week-old Tg26 mice and analyzed them after 9 d. Tubular dilatation and glomerular histology were markedly improved in Tg26 mice injected with Ad-Dkk1 compared with Tg26 mice injected with Ad-Fc (Fig. 6e) . Podocyte hyperplasia and the percentage of collapsed glomeruli were significantly lower in the Ad-Dkk1-injected Tg26 mice compared to the Ad-Fc controls (Fig. 6f,g) . The percentage of glomeruli showing segmental or global glomerulosclerosis was not significantly lower in the Dkk1-treated group than in the Fc-treated group, suggesting that Wnt inhibition has little effect on glomeruli that reach an advanced stage of injury and scarring at the time of injection ( Fig. 6g) . Immunohistochemistry analysis showed substantially more podocyte differentiation ( Fig. 6h and Supplementary Fig. 6a) , and a reduced percentage of glomeruli with proliferating cells ( Fig. 6i and Supplementary Fig. 6b) npg perhaps owing to the prevalence of scarring within the glomerulus in the Tg26 model (Supplementary Fig. 6c ). Assessment of proteinuria at later time points was not possible because of the deleterious effects of systemic Wnt inhibition on the gastrointestinal tract 41 . Together, these results show that podocytes are markedly normalized upon Wnt pathway inhibition in both i-TERT ci and Tg26 models and suggest new avenues for the development of therapeutic strategies to ameliorate disease in patients with the collapsing variant of FSGS.
DISCUSSION
Although kidney podocytes are thought to lack substantial regenerative capacity, we found that podocytes can dedifferentiate and enter the cell cycle in i-TERT mice, and then revert to their original state and resume their role in supporting filtration after TERT expression is silenced or when Wnt signaling is inhibited. Wnt signals are important for kidney development [42] [43] [44] and have been implicated in the repair of damaged kidney tubules 45, 46 . Wnt signaling has also been shown to contribute to podocyte dysfunction in a mouse model of classical FSGS, in which adriamycin treatment causes podocyte damage, but results in neither podocyte dedifferentiation or proliferation 47, 48 . Furthermore, nuclear β-catenin was detected in podocytes in human classical FSGS samples 47 . The common activation of Wnt signaling in classical FSGS on one hand and in i-TERT mice and HIVAN on the other hand indicates that Wnt signaling can result in fundamental differences in podocyte phenotype depending on context. The more markedly altered podocyte phenotype in the i-TERT model and other collapsing glomerulopathies, compared with classical FSGS, may relate to differences in TERT levels, the strength of the Wnt signal or the expression of other cellular or viral cofactors. In the i-TERT model, persistent podocyte proliferation depends upon continued expression of TERT and active Wnt signaling, indicating that these two pathways collaborate to drive the proliferating podocyte phenotype. Consistent with this hypothesis, enforced expression of activated β-catenin alone in the podocyte lineage leads to alterations in the glomerular basement membrane but is insufficient to induce the collapsing form of FSGS 49 . Our data suggest that TERT upregulation and Wnt activation in collapsing glomerulopathies may reflect a reactivation of these regenerative pathways to an extent not seen in FSGS, perhaps corresponding to an earlier stage of podocyte development.
In healthy mice and humans, mature podocytes are quiescent, express high levels of CDK inhibitors and are differentiated, suggesting that these cells may lack the ability to renew during adult life. Our findings challenge this idea and suggest that podocytes, like other epithelial cells, have regenerative potential. The notable reversibility of podocyte cycling seen in i-TERT mice may reflect a normal program of renewal that occurs throughout life as damaged podocytes need to be replenished. Because of the complex anatomy of the glomerulus and the structural function served by podocytes on the basement membrane, renewing podocytes may be rare and therefore elude easy detection. In the i-TERT model and in HIVAN or perhaps even in wild-type mice with injury or with advancing age, podocytes may renew either through a cell-duplication mechanism, in which podocytes enter the cell cycle to produce new daughter cells, or through a facultative stem cell model. The recent finding of putative progenitor cells within the parietal epithelial layer of Bowman's capsule capable of regenerating podocytes is also consistent with replenishment of podocytes under certain conditions 17, 18, 50 .
We speculate that the podocyte depletion seen in many forms of glomerulosclerosis may occur because disease processes fail to activate, interfere with or exhaust podocyte renewal. In this case, drugs that activate telomerase or Wnt signaling may improve glomerular function. Conversely, in collapsing glomerulopathies, where podocytes are hyper-proliferative, telomerase inhibitors or Wnt inhibitors may cause podocyte differentiation, as we have shown with TERT withdrawal and with the use of systemic Dkk1, leading to stabilization of glomerular structure and improved glomerular function. Our data indicate that the telomerase and Wnt pathways are crucial in podocyte biology and suggest new therapeutic strategies to enhance podocyte regeneration, differentiation and repair in glomerular disease.
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/naturemedicine/.
Note: Supplementary information is available on the Nature Medicine website.
